• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Diffuse lung disease: combined clinical and laboratory studies.

作者信息

du Bois R M

机构信息

Royal Brompton Hospital, London.

出版信息

J R Coll Physicians Lond. 1994 Jul-Aug;28(4):338-46.

PMID:7965974
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC5401073/
Abstract
摘要
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1d70/5401073/14129d08783e/jrcollphyslond90366-0065-a.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1d70/5401073/9a69d4874bfe/jrcollphyslond90366-0058-a.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1d70/5401073/d7d969436a0c/jrcollphyslond90366-0059-a.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1d70/5401073/465136bd3802/jrcollphyslond90366-0060-a.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1d70/5401073/7f44e87a4ab0/jrcollphyslond90366-0061-a.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1d70/5401073/97fbcff3e689/jrcollphyslond90366-0062-a.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1d70/5401073/f1ad206e7c9c/jrcollphyslond90366-0063-a.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1d70/5401073/bc7ee79e047c/jrcollphyslond90366-0063-b.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1d70/5401073/7eecd6f5195b/jrcollphyslond90366-0064-a.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1d70/5401073/14129d08783e/jrcollphyslond90366-0065-a.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1d70/5401073/9a69d4874bfe/jrcollphyslond90366-0058-a.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1d70/5401073/d7d969436a0c/jrcollphyslond90366-0059-a.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1d70/5401073/465136bd3802/jrcollphyslond90366-0060-a.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1d70/5401073/7f44e87a4ab0/jrcollphyslond90366-0061-a.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1d70/5401073/97fbcff3e689/jrcollphyslond90366-0062-a.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1d70/5401073/f1ad206e7c9c/jrcollphyslond90366-0063-a.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1d70/5401073/bc7ee79e047c/jrcollphyslond90366-0063-b.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1d70/5401073/7eecd6f5195b/jrcollphyslond90366-0064-a.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1d70/5401073/14129d08783e/jrcollphyslond90366-0065-a.jpg

相似文献

1
Diffuse lung disease: combined clinical and laboratory studies.弥漫性肺疾病：临床与实验室联合研究
J R Coll Physicians Lond. 1994 Jul-Aug;28(4):338-46.
2
Progressive systemic sclerosis and the lung.进行性系统性硬化症与肺
Curr Opin Pulm Med. 1998 Sep;4(5):305-9. doi: 10.1097/00063198-199809000-00011.
3
Systemic sclerosis sine scleroderma presenting as pulmonary intersticial fibrosis.无硬皮病的系统性硬化症表现为肺间质纤维化。
Clin Rheumatol. 2006 May;25(3):382-3. doi: 10.1007/s10067-005-0026-z. Epub 2005 Oct 7.
4
Scleroderma lung study (SLS): differences in the presentation and course of patients with limited versus diffuse systemic sclerosis.硬皮病肺部研究（SLS）：局限性与弥漫性系统性硬化症患者在临床表现和病程上的差异。
Ann Rheum Dis. 2007 Dec;66(12):1641-7. doi: 10.1136/ard.2007.069518. Epub 2007 May 7.
5
Decrease in DL,CO in systemic sclerosis correlates with acceleration of DTPA clearance.系统性硬化症中一氧化碳弥散量（DL,CO）的降低与二乙三胺五乙酸（DTPA）清除加速相关。
Eur Respir J. 1999 Sep;14(3):728-9. doi: 10.1034/j.1399-3003.1999.14c42.x.
6
Circulating endothelin-1 levels in systemic sclerosis subsets--a marker of fibrosis or vascular dysfunction?
J Rheumatol. 1996 Apr;23(4):789-91.
7
[Diffuse fibrosing alveolitis].
Vutr Boles. 1980;19(4):1-8.
8
[Functional diagnosis of diffuse interstitial pulmonary fibrosis].
Poumon Coeur. 1973;29(5):553-65.
9
[Lung function disturbances in fibrosis].
Internist (Berl). 1974 Jul;15(7):364-9.
10
Scleroderma and related conditions.
Med Clin North Am. 1997 Jan;81(1):129-49. doi: 10.1016/s0025-7125(05)70508-3.

本文引用的文献

1
Idiopathic pulmonary fibrosis.特发性肺纤维化
Annu Rev Med. 1993;44:441-50. doi: 10.1146/annurev.me.44.020193.002301.
2
Clearance of inhaled 99mTc-DTPA predicts the clinical course of fibrosing alveolitis.
Eur Respir J. 1993 Jun;6(6):797-802.
3
Serial CT in fibrosing alveolitis: prognostic significance of the initial pattern.特发性肺纤维化的系列CT检查：初始影像模式的预后意义
AJR Am J Roentgenol. 1993 Dec;161(6):1159-65. doi: 10.2214/ajr.161.6.8249719.
4
The predictive value of appearances on thin-section computed tomography in fibrosing alveolitis.薄层计算机断层扫描表现对纤维化肺泡炎的预测价值。
Am Rev Respir Dis. 1993 Oct;148(4 Pt 1):1076-82. doi: 10.1164/ajrccm/148.4_Pt_1.1076.
5
Accuracy of the typical computed tomographic appearances of fibrosing alveolitis.
Thorax. 1993 Apr;48(4):334-8. doi: 10.1136/thx.48.4.334.
6
Fibrosing alveolitis in systemic sclerosis. Bronchoalveolar lavage findings in relation to computed tomographic appearance.系统性硬化症中的纤维化肺泡炎。支气管肺泡灌洗结果与计算机断层扫描表现的关系。
Am J Respir Crit Care Med. 1994 Aug;150(2):462-8. doi: 10.1164/ajrccm.150.2.8049830.
7
Cryptogenic fibrosing alveolitis: response to corticosteroid treatment and its effect on survival.隐源性纤维性肺泡炎：对皮质类固醇治疗的反应及其对生存的影响。
Thorax. 1980 Aug;35(8):593-9. doi: 10.1136/thx.35.8.593.
8
Cryptogenic fibrosing alveolitis: clinical features and their influence on survival.隐源性纤维性肺泡炎：临床特征及其对生存的影响。
Thorax. 1980 Mar;35(3):171-80. doi: 10.1136/thx.35.3.171.
9
Prognosis of cryptogenic fibrosing alveolitis.隐源性纤维性肺泡炎的预后
Thorax. 1983 May;38(5):349-55. doi: 10.1136/thx.38.5.349.
10
Immunohistological analysis of lung tissue from patients with cryptogenic fibrosing alveolitis suggesting local expression of immune hypersensitivity.对隐源性纤维性肺泡炎患者肺组织的免疫组织学分析表明存在免疫超敏反应的局部表达。
Thorax. 1985 Jun;40(6):405-11. doi: 10.1136/thx.40.6.405.